The effect of herbal vitamin cream on preventing scarring

The effect of stop scar cream on the prevention of scar formation in sutured wounds caused by biopsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220730055580N1

Enrollment

Registered

2023-01-17

Start date

2022-08-14

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scars caused by wounds (keloid, hypertrophic, atrophic). Hypertrophic scar

Interventions

Intervention 1: Scar Top cream (made by a clinical pharmacist in the laboratory) is used for the intervention group and zinc oxide ointment is used for the control group. Then the common cream and tre

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. People aged 18-60 years 2.Not suffering from acute or chronic diseases (any diseases such as diabetes, etc.) 3. No history of active skin disease 4. Insensitivity to herbal medicines 5. Not using drugs that interfere with wound healing, such as corticosteroids 6. No history of diseases interfering with wound healing 7. Willingness to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients with oozing wounds with tissue loss 2. Malnourished patients 3. Patients with various malignancies 4. Patients with a history of radiotherapy 5. Use of corticosteroids for more than a week 6. Non-cooperation in intervention such as non-cooperation in regular and timely use of cream 7. Unwillingness to continue participating in the study for any reason

Design outcomes

Primary

Measure	Time frame
Vascularity. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: Patient and Observer Scar Assessment Scale.;Pigment:. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Thickness. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Flexibility. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Surface area. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.	—

Measure

Time frame

Vascularity. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: Patient and Observer Scar Assessment Scale.;Pigment:. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Thickness. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Flexibility. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.;Surface area. Timepoint: On the day of the intervention and the day of the end of the study. Method of measurement: POSAS scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohamad parsa tabar

Tehran University of Medical Sciences

mohamadparsatbar@gmail.com+98 61 4238 8491

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026